Website Terms of Use Privacy Policy Cookie Policy Copyright HGF © 2021 All Rights Reserved.
Copyright HGF © 2021 All Rights Reserved.
It is well accepted that the development of new medical devices is very resource-intensive. It is, therefore no surprise that companies apply for patent protection for new medical devices with the aim of recouping their research & development costs. Patent protection provides a period of exclusivity during which...
By Dr Jennifer Unsworth & Dr Jennifer Uno
Healthcare Scanner
NEWS & EVENTS
Issue 5 - January 2023
Welcome to Issue 5 of the HGF Healthcare Scanner, a regular newsletter from HGF covering IP news and issues in the healthcare sector.
In this issue we have many great articles written by HGF. Dr Jennifer Unsworth and Dr Jennifer Uno explain patent protection for medical devices. Rebecca Field and Melissa Buamah discuss trade mark protection for digital health products. Dr Claire Irvine's article details how to navigate the CRISPR IP confusion. Punita Shah explores healthcare and climate change. Lauren Somers looks at parallel importation of pharmaceuticals in Denmark. Finally, Ellie Purnell explores how CRISPR Edited T cells win the TvT Battle.
The use and creation of digital healthcare products is on the rise as companies look to create a unique selling point and a differentiator in a crowded market. One of the many ways that businesses within the healthcare industry can benefit from this, is through the use of Trade Marks. What is digital healthcare?..
By Rebecca Field & Melissa Buamah
It is just over 10 years since the Science publication of Jinek et al. showed for the first time that DNA cleavage could be achieved in vitro with a Cas9 enzyme of a bacterial CRISPR system using a single guide RNA thereby laying the foundation for a Nobel prize and a revolution in gene modification, yet the patenting situation covering the...
By Dr Claire Irvine
Climate change is the greatest health threat that the world has faced over the last century. Whilst the effect of climate change on health has been acknowledged for some time, it is only recently that the role of the healthcare industry as an active participant in tackling the climate crisis has become more widely appreciated...
By Punita Shah
The repackaging of pharmaceutical products by parallel importers is a long debated subject. The question "when is repackaging necessary" was reconsidered in a set of judgements by the CJEU in November last year. Since 2019, as a result of the implementation of a new EU Regulation, all medicinal products for human use in the EU...
By Lauren Somers
T-cells which have been modified using CRISPR base editing technology have been successfully used to treat T-cell acute lymphoblastic leukaemia for the first time. A 13 year old patient suffering from T-cell acute lymphoblastic leukaemia (T-ALL) was enrolled in the ‘TvT’ clinical trial...
By Ellie Purnell
